细菌荧光成像作为烧伤创面皮肤移植整合的预测指标
这项单中心前瞻性观察研究纳入38例既往感染创面已临床和微生物学清洁的成年烧伤患者,在移植前进行荧光成像评估(手术团队设盲)定位细菌负荷>10^4 CFU/gr的区域。结果显示荧光成像预测移植失败的敏感度86%、特异度98%、PPV 72%、NPV 99%、准确率94%,而拭子微生物学敏感度30%、特异度76%。作者认为荧光成像能准确评估受区并预测移植结局。
要点
- 荧光成像预测任何类型移植失败的敏感度86%、特异度98%、准确率94%。
- 拭子微生物学预测移植失败的敏感度30%、特异度76%。
- 38例中25例完全成活、13例部分失败,无全部失败。
核心结论
- 荧光成像是一种准确评估受区并预测烧伤患者皮肤移植结局的方法。
- 这些发现提示荧光成像可为移植决策提供更好的信息,从而可能带来更好的结局。
研究设计与样本
- 单中心前瞻性观察研究,纳入38例既往感染创面已临床和微生物学清洁、因此适合移植的成年烧伤患者。
- 移植前进行荧光成像评估(手术团队设盲),定位中高细菌负荷(>10^4 CFU/gr)阳性区域。
- 术中由手术团队从受区采集标准拭子样本。
- 术后将荧光阳性/阴性区域与移植成活/失败区域在二维示意图上重叠并测量(cm2)。
主要发现
- 平均总体表面积(TBSA)受累为14.5 ± 12.4 %[范围0.8 - 40.2 %]。
- 38例受试者中25例完全成活,13例部分失败,无全部失败。
- 移植失败区域中荧光成像阳性为100 %,而拭子微生物学阳性为31 %(4/13)。
- 荧光成像预测整个队列中任何类型或范围移植失败的敏感度86 %、特异度98 %、PPV 72 %、NPV 99 %、准确率94 %。
- 拭子样本微生物学的敏感度30 %、特异度76 %。
临床怎么用
- 作者认为荧光成像可为移植决策提供更好的信息,从而可能带来更好的结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Split-thickness skin graft (STSG)1 integration rates are susceptible to improvement. Infection and/or biofilm should be appropriately addressed prior to grafting to improve the likelihood of graft-take. Incorporating technological aids such as fluorescence (FL)2 imaging (MolecuLight®), which accurately locates areas of bacterial loads above 104 CFU/gr, for graft site assessment and preparation could yield better outcomes. METHODS: This single-center, prospective observational study included adult burn patients with previously infected wounds that had been deemed clinically and microbiologically clean and were therefore candidates for grafting. Prior to grafting, a FL imaging assessment (blinded to the surgical team) localized areas positive for moderate-high bacterial loads (>104 CFU/gr). Intra-operatively, a standard swab sample from the recipient site was collected by the surgical team. Postoperatively, areas positive/negative for FL and areas of graft take and failure were overlapped and measured (cm2) over a 2D schematic. The performance and accuracy of FL imaging and swab sampling in relation to graft outcomes were assessed. RESULTS: 38 patients were enrolled in the study. The mean total body surface area (TBSA)3 involvement was 14.5 ± 12.4 % [range 0.8 - 40.2 %]. 25/38 of the subjects enrolled had complete graft take while 13 had partial graft losses. There were no total losses. FL-imaging was positive in 100 % of losses versus 31 % (4/13) of the swab microbiology. FL-imaging was found to have a sensitivity of 86 %, specificity of 98 %, PPV of 72 %, NPV of 99 %, and an accuracy of 94 % for predicting any type or range of graft loss in the entire cohort. Meanwhile, the sensitivity of microbiology from swab samples was 30 %, with a specificity of 76 %. CONCLUSIONS: FL imaging is an accurate method for assessing recipient sites and predicting the outcome of a skin graft among burn patients. These findings suggest that FL imaging can inform better decision-making surrounding grafts that may lead to better outcomes. LEVEL OF EVIDENCE: Level IIA, Therapeutic study.
引用
- Hanson-Viana E, Rojas-Ortiz JA, Rendón-Medina MA, et al. Bacterial fluorescence imaging as a predictor of skin graft integration in burn wounds. Burns. 2024. PMID: 38735804. doi:10.1016/j.burns.2024.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。